CILcare is a Smart R&D Platform specialized in hearing disorders. On an international market, CILcare proposes to its clients and partners to accelerate the development of their drug candidates by testing their efficacy on preclinical pharmacological models and by supporting them in the preparation of their health product development plans. If the importance of investigating tinnitus and hearing loss is pointed out, the underlying fundamental knowledge, based on animal models and the translational mindset are severely lacking. CILcare’s offer fills this gap by providing means to validate hypotheses toward solutions able to prevent and to reduce hearing disorders. The company is located in Montpellier, Boston, Paris, and Copenhagen. CILcare is benefiting from strong expertise and an international network of clients and partners.